|
|
||||||||
Departments of 1 Medicine, 2 Molecular Physiology and Biological Physics, and 3 Chemistry, University of Virginia, Charlottesville, Virginia 22908
We sought to determine the mechanisms
responsible for the reduced renal tissue injury by agonists of
A2A adenosine receptors (A2A-ARs) in models of
ischemia-reperfusion (I/R) injury. DWH-146e, a selective
A2A-AR agonist, was administered subcutaneously to Sprague-Dawley rats and C57BL/6 mice via osmotic minipumps, and animals
were subjected to I/R. I/R led to an increase in plasma creatinine and
kidney neutrophil infiltration. Infusion of DWH-146e at 10 ng · kg
1 · min
1 produced a
70% reduction in plasma creatinine as well as a decrease in neutrophil
density in outer medulla and cortex and myeloperoxidase activity in the
reperfused kidney. Myeloperoxidase activity in kidney correlated with
the degree of renal injury. P-selectin and intercellular adhesion
molecule 1 (ICAM-1) immunoreactivity were most prominent in endothelial
cells of peritubular capillaries and interlobular arteries of cortex
and outer and inner medulla of vehicle-treated mice whose kidneys were
subjected to I/R. DWH-146e treatment led to a pronounced decrease in
P-selectin- and ICAM-1-like immunoreactivity. These data are consistent
with our hypothesis that A2A-AR agonists limit I/R injury
due to an inhibitory effect on neutrophil adhesion.
acute renal failure; neutrophil-endothelial cell interaction; intercellualr adhesion molecule 1; P-selectin
This article has been cited by other articles:
![]() |
A. Ahmad, S. Ahmad, L. Glover, S. M. Miller, J. M. Shannon, X. Guo, W. A. Franklin, J. P. Bridges, J. B. Schaack, S. P. Colgan, et al. Adenosine A2A receptor is a unique angiogenic target of HIF-2{alpha} in pulmonary endothelial cells PNAS, June 30, 2009; 106(26): 10684 - 10689. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, J. Linden, S. S. Berr, I. L. Kron, G. A. Beller, and B. A. French Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2328 - H2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Lisle, L. M. Gazoni, L. G. Fernandez, A. K. Sharma, A. M. Bellizzi, G. D. Schifflett, V. E. Laubach, and I. L. Kron Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1280 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Yeboah, X. Xue, M. Javdan, M. Susin, and C. N. Metz Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury Am J Physiol Renal Physiol, September 1, 2008; 295(3): F654 - F661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hasko and P. Pacher A2A receptors in inflammation and injury: lessons learned from transgenic animals J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman Purinergic receptors in gastrointestinal inflammation Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, V. E. Laubach, D. P. Mulloy, A. Bellizzi, E. B. Unger, J. Linden, P. I. Ellman, T. C. Lisle, and I. L. Kron Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 156 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grenz, H. Zhang, J. Weingart, S. von Wietersheim, T. Eckle, J. Schnermann, C. Kohle, D. Kloor, C. H. Gleiter, V. Vallon, et al. Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1501 - F1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, M. Kim, J. D. Joo, G. Gallos, J.-F. Chen, and C. W. Emala A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R959 - R969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Awad, H. Ye, L. Huang, L. Li, F. W. Foss Jr., T. L. Macdonald, K. R. Lynch, and M. D. Okusa Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1516 - F1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Awad, L. Huang, H. Ye, E. T. A. Duong, W. K. Bolton, J. Linden, and M. D. Okusa Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F828 - F837. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Reece, V. E. Laubach, C. G. Tribble, T. S. Maxey, P. I. Ellman, P. S. Warren, A. M. Schulman, J. Linden, J. A. Kern, and I. L. Kron Adenosine A2A Receptor Agonist Improves Cardiac Dysfunction From Pulmonary Ischemia-Reperfusion Injury Ann. Thorac. Surg., April 1, 2005; 79(4): 1189 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Day, L. Huang, H. Ye, J. Linden, and M. D. Okusa Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages Am J Physiol Renal Physiol, April 1, 2005; 288(4): F722 - F731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Day, M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G285 - G293. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Schwarzschild, K. Xu, E. Oztas, J. P. Petzer, K. Castagnoli, N. Castagnoli Jr., and J.-F. Chen Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease Neurology, December 9, 2003; 61(90116): S55 - 61. [Abstract] [Full Text] |
||||
![]() |
M. D. Okusa, H. Ye, L. Huang, L. Sigismund, T. Macdonald, and K. R. Lynch Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury Am J Physiol Renal Physiol, September 1, 2003; 285(3): F565 - F574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sola, J. Panes, C. Xaus, and G. Hotter Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine J. Leukoc. Biol., January 1, 2003; 73(1): 74 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Cassada, C. G. Tribble, S. M. Long, A. K. Kaza, J. Linden, J. M. Rieger, D. Rosin, I. L. Kron, and J. A. Kern Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons Ann. Thorac. Surg., September 1, 2002; 74(3): 846 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Okusa A2A adenosine receptor: a novel therapeutic target in renal disease Am J Physiol Renal Physiol, January 1, 2002; 282(1): F10 - F18. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Morrison, M. A. H. Talukder, C. Ledent, and S. J. Mustafa Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H437 - H444. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |